AMAG Pharma (AMAG) Reports FDA Approval of Supplemental New Drug Application for Feraheme (ferumoxytol injection)

February 5, 2018 8:09 AM

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that the U.S. Food and Drug Administration (FDA) has approved its application to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found